Contract 75N93018C00039
Via Therapeutics, Llc · Department Of Health And Human Services · August 9, 2018
Via Therapeutics, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 9, 2018 for $3.60 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Austin, TX. It was awarded under a small business set-aside. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 19, 2022.
Contract details
- PIID
- 75N93018C00039
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Austin, TX
- First action
- August 9, 2018
- Latest action
- December 19, 2022
Description
IPP - INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI
Modification timeline
-
December 19, 2022Mod P00006$0
-
December 10, 2021Mod P00005EO14042 INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$0
-
October 18, 2021Mod P00004EO14042 INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$0
-
May 3, 2021Mod P00003INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$0
-
October 16, 2020Mod P00002INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$0
-
July 29, 2020Mod P00001INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$3.00M
-
August 9, 2018Base awardINHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI$599.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $20.43M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $28.31B |
| 2 | California Institute Of Technology | 818 | $19.55B |
| 3 | Lockheed Martin Corp | 28 | $9.64B |
| 4 | The Aerospace Corporation | 393 | $8.97B |
| 5 | Lockheed Martin Corp | 23 | $7.69B |
| 6 | The Johns Hopkins University Applied Physics Laboratory Llc | 1,336 | $7.27B |
| 7 | Leidos Biomedical Research Inc | 167 | $6.23B |
| 8 | The Mitre Corporation | 398 | $6.07B |
| 9 | Lockheed Martin Corporation | 15 | $5.04B |
| 10 | Booz Allen Hamilton Inc | 169 | $4.28B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93018C00039?
Contract 75N93018C00039 is a federal contract awarded to Via Therapeutics, Llc by Department Of Health And Human Services on August 9, 2018 for $3.60 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 6 times since the base award.
Who won contract 75N93018C00039?
Via Therapeutics, Llc won contract 75N93018C00039 from Department Of Health And Human Services.
How much is contract 75N93018C00039 worth?
Contract 75N93018C00039 has obligated $3.60 million to date.